GLIDE's 2023 Annual Report highlights the sustained progress of our partnerships, programs, and initiatives aimed at eliminating infectious diseases. The report showcases significant milestones achieved through collaborative efforts throughout the year.
GLIDE funds nine winning projects from this year’s Falcon Award: The Climate Edit to undertake formative research in new and under-explored areas of the climate and infectious disease nexus.
GLIDE's 2022 Annual Report presents the continuing of our partnerships, programs, and initiatives as we begin to observe the impact of our work on the elimination efforts toward ending infectious diseases.
GLIDE, with support from McKinsey Consulting, developed an innovative finance (IF) workstream to coordinate and lead a 6-month technical exercise with a small core group of 20 organizations, including representatives from traditional pharmaceutical companies, NGOs, product development partnerships, and civil society.
GLIDE, Bridges to Development, and the Zanzibar Ministry of Health convened a workshop with malaria and NTD program managers to identify impactful and feasible win-win integration opportunities.
GLIDE, Bridges to Development, and the Ghana Health Service convened a workshop with malaria and NTD program managers to identify impactful and feasible win-win integration opportunities.
The GEAR is an independent review and evaluation method designed by GLIDE and Bridges to Development team to assess disease elimination and eradication programs.
This white paper explores lessons learned from past successes and failures in disease elimination and eradication efforts, and shares some potential ways forward.
This brief outlines how GLIDE's strategy and scope of work aligns with the targets set by the Sustainable Development Goals contained in the 2030 Agenda for Sustainable Development.
This white paper examines case studies of integration to extract lessons learned which can guide future integration efforts to achieve greater impact and increased efficiency for NTDs.
Our Strategic Plan 2021-2024 outlines how we will build upon existing efforts in disease elimination and identify gaps in knowledge so that we can help consign diseases of poverty to the history books.
